These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase. Teschemacher A, Lemoine H. J Pharmacol Exp Ther; 1999 Mar; 288(3):1084-92. PubMed ID: 10027845 [Abstract] [Full Text] [Related]
5. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. Green SA, Spasoff AP, Coleman RA, Johnson M, Liggett SB. J Biol Chem; 1996 Sep 27; 271(39):24029-35. PubMed ID: 8798639 [Abstract] [Full Text] [Related]
18. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Nials AT, Sumner MJ, Johnson M, Coleman RA. Br J Pharmacol; 1993 Feb 27; 108(2):507-15. PubMed ID: 8095419 [Abstract] [Full Text] [Related]
19. Activation of a beta 2-adrenergic receptor/Gs alpha fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting proliferation of two cancer cell lines. Bertin B, Jockers R, Strosberg AD, Marullo S. Recept Channels; 1997 Feb 27; 5(1):41-51. PubMed ID: 9272575 [Abstract] [Full Text] [Related]
20. Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol. Szczuka A, Wennerberg M, Packeu A, Vauquelin G. Br J Pharmacol; 2009 Sep 27; 158(1):183-94. PubMed ID: 19594756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]